ABSTRACT Transforming growth factor (3 (TGF-13) is produced by bone cells, is abundant in bone matrix, and regulates bone cell biochemical processes. In osteoblast-enriched fetal rat parietal bone cell cultures, low TGF-18 doses increase DNA synthesis, whereas higher levels are less mitogenic, stimulate collagen production, and decrease alkaline phosphatase activity. Parathyroid hormone by itself has minimal effects on these processes, but it opposes the effects of TGF-.f and alters TGF-13 binding to its receptors in osteoblastenriched cultures. Some functions ascribed to parathyroid hormone in bone may therefore result from alterations in TGF-(3 activity, suggesting that the local effects of TGF-13 in bone are under systemic hormonal control.
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Although resorption is the most thoroughly studied effect of parathyroid hormone (PTH) on bone, the hormone also stimulates biochemical processes associated with bone formation (1) (2) (3) (4) . PTH does not directly affect bone-resorbing osteoclasts, and the osteoblast or its products appear to mediate all of the effects of PTH in bone (5-7). The mechanisms by which PTH regulates bone metabolism are incompletely known, but part of its action may involve cyclic AMP generation (1, 2, 8) and local growth factors (9) (10) (11) (12) . One local factor produced by bone cells that is abundant in bone matrix is transforming growth factor (3 (TGF-3) (11) (12) (13) , and TGF-,B regulates replication, collagen synthesis, and alkaline phosphatase in osteoblast-enriched cell cultures (13, 14) . TGF-,B content increases in bone culture medium after PTH treatment (15) , and locally released TGF-f3 could account for the anabolic effects of the hormone on bone. The relationships among these factors in regulating bone formation are unknown. The present studies using osteoblast-enriched primary cell cultures address the combined effects of PTH and TGF-(3 on bone cell activity and the influence of PTH on the association of TGF-13 with bone cell receptors.
MATERIALS AND METHODS
Growth Regulators. Recombinant human TGF-P (rhTGF-,B; provided by H. Michael Shepard, Genentech, South San Francisco, CA) was stored at 20 ,ug/ml in 0.5 M acetic acid at 4°C. Parathyroid hormone (bovine PTH-(1-84), National Hormone and Pituitary Program, Baltimore; rat PTH-(1-34), Calbiochem) was solubilized at a concentration of 10 -M in sterile water containing bovine serum albumin at 4 mg/ml and was stored at -70°C.
Cell Cultures. Parietal bones obtained from 22-day-old rat fetuses (Sprague-Dawley, Charles River Breeding Laboratories) were dissected free of sutures and were subjected to five 20-min collagenase digestions (14) . Although some overlap is likely, the population released during the first collagenase treatment is enriched with fibroblasts, whereas the last three populations are enriched with cells expressing osteoblastic characteristics (2, 14) . Cells were plated at 12,500 cells per cm2 and were cultured to confluence in Dulbecco's modified Eagle's medium containing 10% fetal bovine serum, ascorbic acid at 100 ,xg/ml, and 20 mM Hepes buffer (GIBCO); cells were serum-deprived for 20 hr, and test factors were added in serum-free medium for 23 hr as described (14, 16) . DNA Synthesis. To assess the mitogenic effects of the added agents, the rate of DNA synthesis was measured in 0.32-cm2 cultures labeled with [3H]thymidine (5 ,uCi/ml, 80 Ci/mmol; 1 Ci = 37 GBq; New England Nuclear) for the last 2 hr ofculture. Cells were lysed in 0.1 M NaOH/0.1% sodium dodecyl sulfate and were acidified with 10% trichloroacetic acid, and acid-insoluble material was collected on glass fiber filters and quantitated by scintillation counting as described (14) .
Collagen Synthesis. Collagen synthesis rates were measured in 2-cm2 cultures labeled with [2,3-3H] proline (25 ACi/ ml, 250 mCi/mmol; New England Nuclear) for the last 2 hr of culture. Then 0.5% Triton X-100 (Sigma) cell lysates were extracted with 10% trichloroacetic acid/acetone, and the acid-insoluble material was digested with nonspecific protease-free bacterial collagenase. The amount of newly synthesized collagen was determined in the enzyme-released supernatants according to the method of Peterkovsky and Diegelmann (17) .
Alkaline Phosphatase Activity. Alkaline phosphatase activity in 0.5% Triton X-100 cell extracts was determined by hydrolysis of p-nitrophenyl phosphate to p-nitrophenol, which was measured by spectroscopy at 410 nm as reported (14) . TGF P CONCENTRATION (pM) nuclei were removed by centrifugation; supernatants were diluted with electrophoresis sample buffer containing 5% 2-mercaptoethanol and were electrophoresed through a 7.5%
acrylamide gel according to Laemmli (19 opposed the decrease in enzyme activity that was induced by TGF-f3 (Table 1) .
For receptor studies, cells were labeled with 125I-TGF-f3 (human platelet TGF-f3) in the presence or absence of unlabeled rhTGF-f3 or PTH. The level ofreceptor-bound 125I-TGF-P was determined by chemical crosslinking, separation on polyacrylamide gels, autoradiography, and densitometry. As shown for other cells (18, 20) , fibroblast-and osteoblastenriched cultures from fetal rat parietal bone possessed three discrete TGF-,8 receptors of Mr values >200,000, 85,000, and 65,000. The most prominently labeled polypeptide in both cultures was of Mr >200,000. Unlabeled rhTGF-13 competed with 15I-TGF-f3 for all receptors and displaced binding of 125I-TGF-,8 at the Mr 65,000 receptor the most effectively in both cultures; displacement required more unlabeled TGF-13 at the Mr 85,000 receptor, but it was also equivalent in both cultures (Fig. 3) . Therefore, the fibroblast-and osteoblastenriched cultures each possessed similar high-affinity Mr 65,000 receptors and lower affinity Mr 85,000 receptors. In Table 2 . Apparent abundance and dissociation constants (Kd) for high-and low-affinity TGF-f3 receptors in fibroblast-enriched and contrast, binding at the Mr >200,000 receptor Mr 65,000 receptor differed in both cultures. By the fibroblast-enriched cultures, displaceme TGF-(3 at the Mr >200,000 receptor in the osteo cultures required more unlabeled ligand, wh reduced ligand affinity at this site (Fig. 3) . Scat was curvilinear and indicated a similar total nt affinity TGF-,8 receptors in both cell populatic low-affinity receptors in the osteoblast-enriche r3-fold lower ligand affinity relative to the fibro cells (Fig. 4 and Fig. 6 . Specifically bound TGF-j3 was determined after subtracting 15% nonspecific background binding. Rat PTH-(1-34) (20 pM) was used.
acid polypeptide, augmented the reduced mitogenic activity seen at supramaximal TGF-,8 concentrations (Fig. 5) .
The effect of PTH on TGF-,8 binding was also quantitated by total I251-TGF-p binding and by Scatchard analysis obtained by using progressively greater amounts of 1251I-TGF-18; 20 pM rat PTH-(1-34) increased binding at high-and lowtor binding and affinity TGF-j3 receptors about 1.5-fold ( Fig. 6 and Table 3 ).
tI bone cell culTo examine if longer PTH treatment could produce a stable bed in Fig. 1 
